GlassScriptPhysician profile
George Mansour
NPI 1194072835
$4,381.65
in general payments reported to CMS, 2019-2025
17 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,013 · 2020: $243 · 2021: $2,275 · 2022: $679 · 2023: $39.72 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $171.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,907.57 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $498.45 | 2019-2022 | |
| Pfizer INC. | $348.45 | 2019 | |
| Neurocrine Biosciences, INC. | $242.57 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $229.39 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $201.04 | 2021-2022 | |
| Lilly USA, LLC | $137.12 | 2019 | |
| Globus Medical, INC. | $132.06 | 2025 | Senza |
| Philips North America LLC | $124.85 | 2019 | |
| Amag Pharmaceuticals, INC. | $124.26 | 2019 | |
| Allergan, INC. | $119.40 | 2020 | |
| Medtronic, INC. | $102.75 | 2021 | |
| Urovant Sciences INC | $99.40 | 2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $36.78 | 2022 | |
| Novartis Pharmaceuticals Corporation | $32.17 | 2021-2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $30.31 | 2021 | |
| Merck Sharp & Dohme LLC | $15.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Mansour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.